PRMT7: a survive-or-die switch in cancer stem cells
Mol Cancer
.
2022 Jun 10;21(1):127.
doi: 10.1186/s12943-022-01602-z.
Author
Christophe Nicot
1
Affiliation
1
Department of Pathology, University of Kansas Medical Center, 3901 Rainbow Boulevard, Kansas City, KS, 66160, USA. cnicot@kumc.edu.
PMID:
35689285
PMCID:
PMC9188132
DOI:
10.1186/s12943-022-01602-z
No abstract available
Publication types
Letter
Comment
MeSH terms
Cell Differentiation
Humans
Neoplasms* / genetics
Neoplastic Stem Cells
Protein-Arginine N-Methyltransferases
Substances
PRMT7 protein, human
Protein-Arginine N-Methyltransferases